Shanghai Model Organisms Center Inc Market Cap ($505.74 Million)
Market Cap & Net Worth: Shanghai Model Organisms Center Inc (688265)
Shanghai Model Organisms Center Inc market cap. Shanghai Model Organisms Center Inc (SHG:688265) has a market capitalization of $505.74 Million (CN¥3.46 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #11825 globally and #3383 in its home market, demonstrating a -7.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Model Organisms Center Inc's stock price CN¥44.33 by its total outstanding shares 77963513 (77.96 Million). Also see 688265 cash generation efficiency for how efficiently the company converts equity into cash flow.
Shanghai Model Organisms Center Inc Market Cap History (2021–2026)
Shanghai Model Organisms Center Inc market cap history from 2021 to 2026. Data shows change from $790.96 Million to $505.74 Million (-8.61% CAGR). Check Shanghai Model Organisms Center Inc (688265) stock price for real-time trading data and today's change.
Shanghai Model Organisms Center Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Model Organisms Center Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 688265 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.11x
Shanghai Model Organisms Center Inc's market cap is 1.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.43x
Shanghai Model Organisms Center Inc's market cap is 14.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $790.96 Million | $275.27 Million | $60.86 Million | 2.87x | 13.00x |
| 2022 | $555.54 Million | $302.97 Million | -$5.40 Million | 1.83x | N/A |
| 2023 | $435.93 Million | $366.55 Million | -$20.58 Million | 1.19x | N/A |
| 2024 | $263.76 Million | $381.24 Million | $6.50 Million | 0.69x | 40.61x |
| 2025 | $467.86 Million | $421.26 Million | $32.43 Million | 1.11x | 14.43x |
Competitor Companies of 688265 by Market Capitalization
Companies near Shanghai Model Organisms Center Inc in the global market cap rankings as of November 8, 2026. Also see how large is Shanghai Model Organisms Center Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to Shanghai Model Organisms Center Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Shanghai Model Organisms Center Inc (2021–2026)
Market capitalization of Shanghai Model Organisms Center Inc from 2021 to today. Between 2021 and today, Shanghai Model Organisms Center Inc's market cap moved from $790.96 Million to $ 505.74 Million, with a yearly change of -8.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥505.74 Million | +8.10% |
| 2025 | CN¥467.86 Million | +77.38% |
| 2024 | CN¥263.76 Million | -39.49% |
| 2023 | CN¥435.93 Million | -21.53% |
| 2022 | CN¥555.54 Million | -29.76% |
| 2021 | CN¥790.96 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Shanghai Model Organisms Center Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $505.74 Million USD |
| MoneyControl | $505.74 Million USD |
| MarketWatch | $505.74 Million USD |
| marketcap.company | $505.74 Million USD |
| Reuters | $505.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai Model Organisms Center Inc
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. It uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. The company offers toolbox of mice; disease mice, such as rare, infectious, a… Read more